26.07.2024 14:47:13 - dpa-AFX: *CHMP RECOMMENDS J&J'S RYBREVANT WITH CHEMO FOR ADVANCED EGFR-MUTATED NSCLC

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX

© 2000-2025 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2025 Infront Financial Technology GmbH